# The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling

> **NCT05000411** · PHASE4 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 268 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Compound Danshen Dropping Pills (CDDP)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05000411
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-25
- **Primary completion:** 2023-08-25
- **Final completion:** 2024-03-01
- **Target enrollment:** 268 (ESTIMATED)
- **Last updated:** 2023-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05000411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05000411, "The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05000411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*